1. Parenteral Dilantin (Phenytoin Sodium Injection, USP) [prescribing information]. Revised February 2013. Parke Davis: New York. http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/010151s037lbl.pdf . Accessed 6 June 2015.
2. Meierkord H, Boon P, Engelsen B, Gocke K, Shorvon S, Tinuper P, et al. EFNS guideline on the management of status epilepticus in adults. Eur J Neurol. 2010;17(3):348–55.
3. Cerebyx (Fosphenytoin Sodium Injection) [prescribing information]. Pfizer Labs: New York. Revised April 2014. http://labeling.pfizer.com/ShowLabeling.aspx?id=749 . Accessed 6 June 2015.
4. Comer J. Extravasation from intravenous phenytoin. Am J Intraven Ther Clin Nutr. 1984;11:23–9.
5. Hanna D. Purple glove syndrome: a complication of intravenous phenytoin. J Neurosci Nurs. 1992;24(6):340–5.